Shukra Pharma.

{
  "main_header": {
    "sid": 505931,
    "name": "Shukra Pharma.",
    "stock_name": "Shukra Pharma.",
    "full_name": "Shukra Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/shukra-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "39.73",
    "chg": -0.78,
    "chgp": "-1.93%",
    "dir": -1,
    "prev_price": "40.51",
    "mcapval": "1,685.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524632,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE551C01044",
    "curr_date": "Feb 01",
    "curr_time": "",
    "bse_nse_vol": "2.13 lacs",
    "exc_status": "Active",
    "traded_date": "Feb 01, 2026",
    "traded_date_str": "2026 02 01",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/shukra-pharma-505931-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "When is the next results date for Shukra Pharmaceuticals Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-shukra-pharmaceuticals-ltd-3815049",
        "imagepath": "",
        "date": "2026-02-01 23:15:55",
        "description": "The next results date for Shukra Pharmaceuticals Ltd is scheduled for 04 February 2026...."
      },
      {
        "title": "Shukra Pharmaceuticals Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/shukra-pharmaceuticals-ltd-is-rated-hold-3799868",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/ShukraPharmaceu_mojoScore_3799868.png",
        "date": "2026-01-22 10:10:41",
        "description": "Shukra Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, a rating that was last updated on 17 Jul 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 22 January 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Shukra Pharmaceuticals Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/shukra-pharmaceuticals-ltd-is-rated-hold-3788791",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/ShukraPharmaceu_mojoScore_3788791.png",
        "date": "2026-01-11 10:10:27",
        "description": "Shukra Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, a rating that was last updated on 17 Jul 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 11 January 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Shukra Pharmaceuticals Ltd Sees Mixed Technical Signals Amid Price Momentum Shift",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shukra-pharmaceuticals-ltd-sees-mixed-technical-signals-amid-price-momentum-shift-3776967",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/ShukraPharmaceu_technicaldot_3776967.png",
        "date": "2026-01-01 08:03:46",
        "description": "Shukra Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, with a recent downgrade in its Mojo Grade from Sell to Hold signalling a cautious optimism among investors. Despite a sharp 4.99% decline in the latest trading session, the stock’s long-term returns remain impressive, though mixed technical indicators suggest a complex near-term outlook."
      },
      {
        "title": "Shukra Pharmaceuticals Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/shukra-pharmaceuticals-ltd-is-rated-hold-3776198",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/ShukraPharmaceu_mojoScore_3776198.png",
        "date": "2025-12-31 10:10:03",
        "description": "Shukra Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, a rating that was last updated on 17 Jul 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 31 December 2025, providing investors with an up-to-date perspective on the stock’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Shukra Pharmaceuticals Ltd Sees Bullish Momentum Amid Technical Upgrades",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shukra-pharmaceuticals-ltd-sees-bullish-momentum-amid-technical-upgrades-3775645",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/ShukraPharmaceu_technicaldot_3775645.png",
        "date": "2025-12-31 08:05:12",
        "description": "Shukra Pharmaceuticals Ltd has witnessed a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. Despite some bearish signals on momentum oscillators like RSI, the overall technical landscape, including MACD and moving averages, suggests strengthening price action. This article analyses the recent technical developments, price performance, and what investors might expect going forward."
      },
      {
        "title": "Why is Shukra Pharmaceuticals Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-shukra-pharmaceuticals-ltd-fallingrising-3771679",
        "imagepath": "",
        "date": "2025-12-27 00:37:51",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Exceptional Long-Term and Recent Returns Drive Confidence</strong></p>\n<p>Shukra Pharmaceuticals has demonstrated extraordinary returns over multiple time horizons, significantly outpacing the benchmark Sensex. Over the past year, the stock has surged by an impressive 398.77%, compared to the Sensex's modest 8.37% gain. Even more striking is the five-year return of 28,269.98%, dwarfing the Sensex's 81.04% increase. This exceptional performance underscores the company's strong growth trajectory and has likely contributed to heightened investor interest.</p>\n<p>In the short term, the stock has also shown remarkable momentum. Over the last month, Shukra Pharmaceuticals gained 51.68%, while the Sensex declined by 0.66%. Despite a slight dip of 0.51% in the past week, the stock remains well above..."
      },
      {
        "title": "Shukra Pharmaceuticals Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shukra-pharmaceuticals-technical-momentum-shifts-amid-mixed-indicator-signals-3766368",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/ShukraPharmaceu_technicaldot_3766368.png",
        "date": "2025-12-23 08:07:24",
        "description": "Shukra Pharmaceuticals has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across key indicators. While the stock’s price momentum shows signs of mild bullishness, certain oscillators and trend analyses suggest caution, underscoring the importance of a balanced view for investors navigating the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Shukra Pharma. Sees Revision in Market Evaluation Amid Mixed Financial Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/shukra-pharma-upgraded-from-sell-to-hold-by-marketsmojo-on-17-july-2025-3764588",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/ShukraPharma_mojoScore_3764588.png",
        "date": "2025-12-20 10:10:04",
        "description": "Shukra Pharma., a microcap player in the Pharmaceuticals & Biotechnology sector, has undergone a revision in its market evaluation reflecting a nuanced shift in its financial and technical outlook. This change comes amid a backdrop of strong stock returns contrasted by recent operational challenges and valuation concerns."
      }
    ],
    "total": 609,
    "sid": "505931",
    "stock_news_url": "https://www.marketsmojo.com/news/shukra-pharmaceuticals-505931"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Unaudited Financial Result For The Third Quarter Ended On 31 December 2025 Along With The Auditors Limited Review Report.",
      "datetime": "30-Jan-2026",
      "details": "Shukra Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2026 inter alia to consider and approve Unaudited financial result for the Third Quarter ended on 31 December 2025 along with the Auditors Limited Review Report.",
      "source": "BSE"
    },
    {
      "caption": "Update on board meeting",
      "datetime": "30-Jan-2026",
      "details": "The Board Meeting to be held on 07/02/2026 has been revised to 04/02/2026 The Board Meeting to be held on 07/02/2026 has been revised to 04/02/2026",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Held On Today",
      "datetime": "28-Jan-2026",
      "details": "Regulation 30 of the Securities and Exchange Board of India (Listing Obligation and Disclosure Requirement) Regulation 2015.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "04 Feb 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Shukra Pharmaceuticals Ltd has declared <strong>1%</strong> dividend, ex-date: 18 Sep 25",
          "dt": "2025-09-18",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Shukra Pharmaceuticals Ltd has announced <strong>1:10</strong> stock split, ex-date: 21 Mar 25",
          "dt": "2025-03-21",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Shukra Pharmaceuticals Ltd has announced <strong>3:1</strong> bonus issue, ex-date: 19 Apr 24",
          "dt": "2024-04-19",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Shukra Pharmaceuticals Ltd has announced <strong>6:1</strong> rights issue, ex-date: 02 Feb 23",
          "dt": "2023-02-02",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

When is the next results date for Shukra Pharmaceuticals Ltd?

2026-02-01 23:15:55

The next results date for Shukra Pharmaceuticals Ltd is scheduled for 04 February 2026....

Read full news article

Shukra Pharmaceuticals Ltd is Rated Hold

2026-01-22 10:10:41

Shukra Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, a rating that was last updated on 17 Jul 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 22 January 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Shukra Pharmaceuticals Ltd is Rated Hold

2026-01-11 10:10:27

Shukra Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, a rating that was last updated on 17 Jul 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 11 January 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

Shukra Pharmaceuticals Ltd Sees Mixed Technical Signals Amid Price Momentum Shift

2026-01-01 08:03:46

Shukra Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, with a recent downgrade in its Mojo Grade from Sell to Hold signalling a cautious optimism among investors. Despite a sharp 4.99% decline in the latest trading session, the stock’s long-term returns remain impressive, though mixed technical indicators suggest a complex near-term outlook.

Read full news article

Shukra Pharmaceuticals Ltd is Rated Hold

2025-12-31 10:10:03

Shukra Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, a rating that was last updated on 17 Jul 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 31 December 2025, providing investors with an up-to-date perspective on the stock’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Shukra Pharmaceuticals Ltd Sees Bullish Momentum Amid Technical Upgrades

2025-12-31 08:05:12

Shukra Pharmaceuticals Ltd has witnessed a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. Despite some bearish signals on momentum oscillators like RSI, the overall technical landscape, including MACD and moving averages, suggests strengthening price action. This article analyses the recent technical developments, price performance, and what investors might expect going forward.

Read full news article

Why is Shukra Pharmaceuticals Ltd falling/rising?

2025-12-27 00:37:51

Exceptional Long-Term and Recent Returns Drive Confidence

Shukra Pharmaceuticals has demonstrated extraordinary returns over multiple time horizons, significantly outpacing the benchmark Sensex. Over the past year, the stock has surged by an impressive 398.77%, compared to the Sensex's modest 8.37% gain. Even more striking is the five-year return of 28,269.98%, dwarfing the Sensex's 81.04% increase. This exceptional performance underscores the company's strong growth trajectory and has likely contributed to heightened investor interest.

In the short term, the stock has also shown remarkable momentum. Over the last month, Shukra Pharmaceuticals gained 51.68%, while the Sensex declined by 0.66%. Despite a slight dip of 0.51% in the past week, the stock remains well above...

Read full news article

Shukra Pharmaceuticals Technical Momentum Shifts Amid Mixed Indicator Signals

2025-12-23 08:07:24

Shukra Pharmaceuticals has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across key indicators. While the stock’s price momentum shows signs of mild bullishness, certain oscillators and trend analyses suggest caution, underscoring the importance of a balanced view for investors navigating the Pharmaceuticals & Biotechnology sector.

Read full news article

Shukra Pharma. Sees Revision in Market Evaluation Amid Mixed Financial Signals

2025-12-20 10:10:04

Shukra Pharma., a microcap player in the Pharmaceuticals & Biotechnology sector, has undergone a revision in its market evaluation reflecting a nuanced shift in its financial and technical outlook. This change comes amid a backdrop of strong stock returns contrasted by recent operational challenges and valuation concerns.

Read full news article

View All News